人乳头瘤病毒相关癌症——美国,2012—2016年
CDC分析美国癌症统计(USCS)2012—2016年数据,评估HPV相关癌症发病并估算HPV归因癌症数。年均报告43,999例HPV相关癌症,其中34,800例(79%)归因于HPV;34,800例中32,100例(92%)归因于9vHPV覆盖型别,女性19,000例、男性13,100例。最常见为宫颈癌(9,700例)和口咽癌(12,600例)。
要点
- 年均34,800例癌症归因于HPV,其中92%归因于9vHPV覆盖型别。
- 归因于9vHPV覆盖型别的癌症女性19,000例、男性13,100例。
- 最常见为宫颈癌9,700例和口咽癌12,600例。
核心结论
- 年均43,999例HPV相关癌症中34,800例(79%)归因于HPV,其中32,100例(92%)归因于9vHPV覆盖型别。
- HPV疫苗接种是可预防这些癌症的重要策略,但2018年仅一半青少年完成HPV疫苗接种。
研究设计与样本
- CDC分析美国癌症统计(USCS)2012—2016年基于人群的癌症登记数据,评估HPV相关癌症发病并估算HPV归因癌症数。
主要发现
- 年均报告43,999例HPV相关癌症,估算34,800例(79%)归因于HPV。
- 34,800例归因于HPV的癌症中,32,100例(92%)归因于9vHPV覆盖型别,女性19,000例、男性13,100例。
- 最常见为宫颈癌(9,700例)和口咽癌(12,600例)。
- 归因于9vHPV覆盖型别的癌症数按州为每年40至3,270例。
关键数值与推荐
- 9vHPV覆盖致癌型别16、18、31、33、45、52、58及非致癌型别6、11。
- 2018年仅一半青少年完成HPV疫苗接种。
临床怎么用
- 基于人群的癌症登记监测数据可用于规划HPV疫苗接种和癌症筛查工作,并监测其长期影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human papillomavirus (HPV) causes nearly all cervical cancers and some cancers of the vagina, vulva, penis, anus, and oropharynx (1).* Most HPV infections are asymptomatic and clear spontaneously within 1 to 2 years; however, persistent infection with oncogenic HPV types can lead to development of precancer or cancer (2). In the United States, the 9-valent HPV vaccine (9vHPV) is available to protect against oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58 as well as nononcogenic types 6 and 11 that cause genital warts. CDC analyzed data from the U.S. Cancer Statistics (USCS)† to assess the incidence of HPV-associated cancers and to estimate the annual number of cancers caused by HPV, overall and by state, during 2012-2016 (3,4). An average of 43,999 HPV-associated cancers were reported annually, and an estimated 34,800 (79%) of those cancers were attributable to HPV. Of these 34,800 cancers, an estimated 32,100 (92%) were attributable to the types targeted by 9vHPV, with 19,000 occurring among females and 13,100 among males. The most common were cervical (9,700) and oropharyngeal cancers (12,600). The number of cancers estimated to be attributable to the types targeted by 9vHPV ranged by state from 40 to 3,270 per year. HPV vaccination is an important strategy that could prevent these cancers, but during 2018, only half of adolescents were up to date on HPV vaccination (5). These surveillance data from population-based cancer registries can be used to inform the planning for, and monitor the long-term impact of, HPV vaccination and cancer screening efforts nationally and within states.
引用
- Senkomago V, Henley SJ, Thomas CC, et al. Human Papillomavirus-Attributable Cancers - United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31437140. doi:10.15585/mmwr.mm6833a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。